Pei-Wen Lim1, Kate H Dinh1, Mary Sullivan1, Wahid Y Wassef2, Jaroslav Zivny2, Giles F Whalen1, Jennifer LaFemina3. 1. Department of Surgery, Division of Surgical Oncology, University of Massachusetts Medical School, Worcester, MA, USA. 2. Department of Medicine, Division of Gastroenterology, University of Massachusetts Medical School, Worcester, MA, USA. 3. Department of Surgery, Division of Surgical Oncology, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: jennifer.lafemina@umassmemorial.org.
Abstract
BACKGROUND: Long-term incidence of endocrine and exocrine insufficiency after pancreatectomy is poorly described. We analyze the long-term risks of pancreatic insufficiency after pancreatectomy. METHODS: Subjects who underwent pancreatectomy from 2002 to 2012 were identified from a prospective database (n = 227). Subjects who underwent total pancreatectomy or pancreatitis surgery were excluded. New post-operative endocrine and exocrine insufficiency was defined as the need for new pharmacologic intervention within 1000 days from resection. RESULTS: 28 (16%) of 178 subjects without pre-existing endocrine insufficiency developed post-operative endocrine insufficiency: 7 (25%) did so within 30 days, 8 (29%) between 30 and 90 days, and 13 (46%) after 90 days. 94 (43%) of 214 subjects without pre-operative exocrine insufficiency developed exocrine insufficiency: 20 (21%) did so within 30 days, 29 (31%) between 30 and 90 days, and 45 (48%) after 90 days. Adjuvant radiation was associated with new endocrine insufficiency. On multivariate regression, pancreaticoduodenectomy and chemotherapy were associated with a greater risk of exocrine insufficiency. CONCLUSION: Reporting 30-day functional outcomes for pancreatic resection is insufficient, as nearly 45% of subjects who develop disease do so after 90 days. Reporting of at least 90-day outcomes may more reliably assess risk for post-operative endocrine and exocrine insufficiency.
BACKGROUND: Long-term incidence of endocrine and exocrine insufficiency after pancreatectomy is poorly described. We analyze the long-term risks of pancreatic insufficiency after pancreatectomy. METHODS: Subjects who underwent pancreatectomy from 2002 to 2012 were identified from a prospective database (n = 227). Subjects who underwent total pancreatectomy or pancreatitis surgery were excluded. New post-operative endocrine and exocrine insufficiency was defined as the need for new pharmacologic intervention within 1000 days from resection. RESULTS: 28 (16%) of 178 subjects without pre-existing endocrine insufficiency developed post-operative endocrine insufficiency: 7 (25%) did so within 30 days, 8 (29%) between 30 and 90 days, and 13 (46%) after 90 days. 94 (43%) of 214 subjects without pre-operative exocrine insufficiency developed exocrine insufficiency: 20 (21%) did so within 30 days, 29 (31%) between 30 and 90 days, and 45 (48%) after 90 days. Adjuvant radiation was associated with new endocrine insufficiency. On multivariate regression, pancreaticoduodenectomy and chemotherapy were associated with a greater risk of exocrine insufficiency. CONCLUSION: Reporting 30-day functional outcomes for pancreatic resection is insufficient, as nearly 45% of subjects who develop disease do so after 90 days. Reporting of at least 90-day outcomes may more reliably assess risk for post-operative endocrine and exocrine insufficiency.
Authors: Irene Epelboym; Megan Winner; Joseph DiNorcia; Minna K Lee; James A Lee; Beth Schrope; John A Chabot; John D Allendorf Journal: J Surg Res Date: 2013-10-09 Impact factor: 2.192
Authors: Edmée C M Sikkens; Djuna L Cahen; Jill de Wit; Caspar W N Looman; Casper van Eijck; Marco J Bruno Journal: J Clin Gastroenterol Date: 2014 May-Jun Impact factor: 3.062
Authors: J J Huang; C J Yeo; T A Sohn; K D Lillemoe; P K Sauter; J Coleman; R H Hruban; J L Cameron Journal: Ann Surg Date: 2000-06 Impact factor: 12.969
Authors: Zhi Ven Fong; Wei Phin Tan; Harish Lavu; Eugene P Kennedy; Donald G Mitchell; Leonidas G Koniaris; Patricia K Sauter; Ernest L Rosato; Charles J Yeo; Jordan M Winter Journal: J Gastrointest Surg Date: 2013-04-04 Impact factor: 3.452
Authors: Yinin Hu; Timothy L McMurry; James M Isbell; George J Stukenborg; Benjamin D Kozower Journal: J Thorac Cardiovasc Surg Date: 2014-04-18 Impact factor: 5.209
Authors: Jiro Kusakabe; Blaire Anderson; Jingxia Liu; Gregory A Williams; William C Chapman; Majella M B Doyle; Adeel S Khan; Dominic E Sanford; Chet W Hammill; Steven M Strasberg; William G Hawkins; Ryan C Fields Journal: J Gastrointest Surg Date: 2019-01-22 Impact factor: 3.452
Authors: Igor E Khatkov; Igor V Maev; Sayyar R Abdulkhalov; Sergey A Alekseenko; Ruslan B Allikhanov; Igor G Bakulin; Natalia V Bakulina; Andrey U Baranovskiy; Ekaterina V Beloborodova; Elena A Belousova; Sergey E Voskanyan; Lyudmila V Vinokurova; Vladimir B Grinevich; Vladimir V Darvin; Elena A Dubtsova; Tatiana G Dyuzheva; Vyacheslav I Egorov; Mikhail G Efanov; Roman E Izrailov; Vyacheslav L Korobka; Bogdan N Kotiv; Nikolay Yu Kokhanenko; Yury A Kucheryavy; Maria A Livzan; Vladimir K Lyadov; Karine A Nikolskaya; Marina F Osipenko; Victor D Pasechnikov; Ekaterina Yu Plotnikova; Oleg A Sablin; Vladimir I Simanenkov; Victor V Tsvirkun; Vladislav V Tsukanov; Alexey V Shabunin; Dmitry S Bordin; Professional Medical Society Pancreatic Club Russia Journal: Turk J Gastroenterol Date: 2021-03 Impact factor: 1.852
Authors: Menghua Dai; Cheng Xing; Ning Shi; Shunda Wang; Guangdong Wu; Quan Liao; Taiping Zhang; Ge Chen; Wenming Wu; Junchao Guo; Ziwen Liu Journal: BMJ Open Diabetes Res Care Date: 2020-10
Authors: Lumír Kunovský; Petr Dítě; Petr Jabandžiev; Michal Eid; Karolina Poredská; Jitka Vaculová; Dana Sochorová; Pavel Janeček; Pavla Tesaříková; Martin Blaho; Jan Trna; Jan Hlavsa; Zdeněk Kala Journal: J Clin Med Date: 2021-12-10 Impact factor: 4.241